Concord Biotech IPO share allotment likely today. Here's how you can check status

economictimes.indiatimes.com:

Concord Biotech IPO will likely be finalised on August 11. Investors will get shares on a lottery basis and the whole process will be supervised by the registrar. On the allotment date, investors get to know about the number of shares allotted to them as against the bids made.

They can check the allotment status through the BSE or by visiting the registrar's website. Here's how you can check the status on BSE. Step 1: Visit the BSE Website Step 2: Select the issue name, that is the company's name in the drop-down.

Step 3: Enter the application number or PAN number to check the allotment status. The company's shares are expected to list on the exchanges on August 18. According to market sources, Concord Biotech is commanding a premium of Rs 150 in the unlisted market.

At the upper price band of Rs 741, the stock is expected to list at a premium of 20%. Fermentation-based API Major Concord Biotech saw 24.86 times subscription for its IPO at close. The qualified institutional buyer portion was booked the most with 67.67 times, non-institutional investors at 16.99 times, whereas, the retail category was subscribed 3.78 times.

The company is one of the leading global manufacturers of select fermentation-based APIs (F-APIs) across immunosuppressants and oncology with a market share of over 20% by volume in 2022. It is present across the fermentation value chain, and supplies to over 70 countries including regulated markets, such as US, Europe and Japan, and India. As of FY23, the company had 23 APIs (89% of revenue), which it aims to increase further, especially in anti-infective/oncology segments.Kotak Mahindra Capital, Jefferies India, Citigroup acted as the book-running lead managers and Link Intime India was the registrar